Latest Whole blood Stories

CaridianBCT, a developer and marketer of blood collection and processing systems to hospitals and blood banks, has initiated a clinical trial for treating whole blood with Mirasol pathogen reduction technology after receiving clearance from the FDA and US Department of Defense. The Mirasol pathogen reduction technology (PRT) system is a proprietary technology that uses riboflavin and UV light to reduce the levels of infectious pathogens and inactivate white cells from collected blood,...

CaridianBCT, a leading global provider of technology, products and services in automated blood collections, therapeutic systems, whole blood processes and pathogen reduction technologies, announced today that it has initiated a clinical trial for treating whole blood with Mirasol Pathogen Reduction Technology (PRT) after receiving clearance from the U.S. Food and Drug Administration (FDA) and U.S. Department of Defense. The Mirasol PRT system is a proprietary technology that uses riboflavin...

BRAINTREE, Mass. and NILES, Ill., Oct. 30 /PRNewswire-FirstCall/ -- Haemonetics Corporation, a global blood management solutions company, and Haemoscope Corporation, a privately held blood diagnostic company, announced today a definitive agreement whereby Haemonetics will acquire Haemoscope's TEG(R) Thrombelastograph(R) Hemostasis Analyzer business for $44 million cash. The acquisition is expected to close within the next several weeks. Haemonetics helps hospitals and blood banks improve...